BIOLASE Inc (BIOL) stock is up 20.69% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives BIOL stock a score of 85 out of a possible 100.
That rank is influenced by a long-term technical score of 98. BIOL's rank also includes a short-term technical score of 84. The fundamental score for BIOL is 73. In addition to the average rating from Wall Street analysts, BIOL stock has a mean target price of 1.383. This means analysts expect the stock to rise 31.71% over the next 12 months.
What's Happening with BIOL Stock Today
BIOLASE Inc (BIOL) stock has gained 8.29% while the S&P 500 is up 0.64% as of 9:54 AM on Wednesday, Jan 20. BIOL is up $0.08 from the previous closing price of $0.97 on volume of 6,263,501 shares. Over the past year the S&P 500 has gained 15.13% while BIOL is up 20.69%. BIOL lost -$0.50 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on BIOLASE Inc (BIOL) Stock.
